DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
SHR3824 is an investigational drug.
There have been 13 clinical trials for SHR3824. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2017.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Liver Diseases. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd. and [disabled in preview].
There are three US patents protecting this investigational drug and thirty-one international patents.
Recent Clinical Trials for SHR3824
|Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes||Jiangsu HengRui Medicine Co., Ltd.||Phase 3|
|Drug-drug Interaction Between Simvastatin and SHR3824||Jiangsu HengRui Medicine Co., Ltd.||Phase 1|
|Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes||Jiangsu HengRui Medicine Co., Ltd.||Phase 3|
Top disease conditions for SHR3824
Top clinical trial sponsors for SHR3824
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|SHR3824||Get Started Free||L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof||Jiangsu Hengrui Medicine Co., Ltd. (Lianyungang, Jiangsu, CN)||Get Started Free|
|SHR3824||Get Started Free||Compounds as peptidic GLP1/glucagon/GIP receptor agonists||SANOFI (Paris, FR)||Get Started Free|
|SHR3824||Get Started Free||Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists||SANOFI (Paris, FR)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|SHR3824||Brazil||BR112017005454||2034-09-30||Get Started Free|
|SHR3824||Canada||CA2961819||2034-09-30||Get Started Free|
|SHR3824||China||CN105992769||2034-09-30||Get Started Free|
|SHR3824||European Patent Office||EP3202772||2034-09-30||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|